{"id":1136,"date":"2020-03-10T14:19:59","date_gmt":"2020-03-10T13:19:59","guid":{"rendered":"https:\/\/dose-innova.ccoo.cat\/?p=1136"},"modified":"2020-03-10T14:19:59","modified_gmt":"2020-03-10T13:19:59","slug":"covid-19-recomanacions-per-a-empreses-i-persones-treballadores","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/covid-19-recomanacions-per-a-empreses-i-persones-treballadores\/","title":{"rendered":"COVID-19: Recomanacions per a empreses i persones treballadores"},"content":{"rendered":"<p>Dilluns passat i avui s\u2019ha reunit el Consell de Relacions Laborals -\u00f2rgan estable de concertaci\u00f3 social format pel Departament de Treball, Afers Socials i Fam\u00edlies, Foment del Treball Nacional, Pimec, CCOO de Catalunya i UGT de Catalunya- per acordar un document de recomanacions per a empreses i persones treballadores sobre el coronavirus SARS-COV-2.<\/p>\n<p>Pots accedir al document mitjan\u00e7ant aquet enlla\u00e7:<\/p>\n<p><a href=\"https:\/\/www.ccoo.cat\/pdf_documents\/2020\/Recomanacions_CRL_sobre_SARS-COV-2_9_03_2020.pdf\"><span style=\"color: #3366ff\"><strong>RECOMANACIONS PER A EMPRESES I PERSONES TREBALLADORES<\/strong><\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;    \t    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dilluns passat i avui s\u2019ha reunit el Consell de Relacions Laborals -\u00f2rgan estable de concertaci\u00f3 social format pel Departament de Treball, Afers Socials i Fam\u00edlies, Foment del Treball Nacional, Pimec, &#8230; <a title=\"COVID-19: Recomanacions per a empreses i persones treballadores\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/covid-19-recomanacions-per-a-empreses-i-persones-treballadores\/\" aria-label=\"Leer m\u00e1s sobre COVID-19: Recomanacions per a empreses i persones treballadores\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":1137,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,26],"tags":[],"class_list":["post-1136","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-towa-pharmaceutical-europe-app-push","category-notesinformatives_ca","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=1136"}],"version-history":[{"count":0,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1136\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/1137"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=1136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=1136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=1136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}